PAUL A. LAVIOLETTE - 04 May 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: Director
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 04 May 2022
Net transactions value: $0
Form type: 4
Filing time: 05 May 2022, 17:54:22 UTC
Previous filing: 08 Dec 2021
Next filing: 15 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Award	$0	+2,300	+88%	$0.000000	4,915	04 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted on May 4, 2022 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.